Compound details
Auriculin
| Compound ID | CDAMM00186 |
|---|---|
| Common name | Auriculin | IUPAC name | 5-hydroxy-7-(2-hydroxy-4-methoxyphenyl)-2,2-dimethyl-10-(3-methylbut-2-enyl)pyrano[3,2-g]chromen-6-one |
| Molecular formula | C26H26O6 |
| Retention time | 48.94 |
|---|---|
| Adduct | [M+Na]+ |
| Actual mz | 457.161 | Theoretical mz | 457.162 |
| Error | 1.96 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 4.8897 |
| Inchi key | VQGWUEFARIAFPF-UHFFFAOYSA-N |
|---|---|
| Smiles | CC(=CCC1=C2C(=C(C3=C1OC=C(C3=O)C4=C(C=C(C=C4)OC)O)O)C=CC(O2)(C)C)C |
| Superclass | Phenylpropanoids and polyketides |
| Class | Isoflavonoids |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| P19838 | NFKB1 | Nuclear factor NF-kappa-B p105 subunit | T83145 | SEA |
| P11926 | ODC1 | Ornithine decarboxylase | T60366 | SEA |
| P18031 | PTPN1 | Protein-tyrosine phosphatase 1B | T16347 | SEA |
| P19838 | NFKB1 | Nuclear factor NF-kappa-B p105 subunit | T83145 | SEA |
| P60568 | IL2 | Interleukin-2 | T61698 | SEA |
| Q9UNQ0 | ABCG2 | ATP-binding cassette sub-family G member 2 | T56556 | SEA |
| P14679 | TYR | Tyrosinase | T97035 | SEA |
| O60911 | CTSV | Cathepsin (V and K) | T93653 | SEA |
| P16152 | CBR1 | Carbonyl reductase [NADPH] 1 | T70518 | SEA |
| P10599 | TXN | Thioredoxin | T85616 | SEA |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T83145 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | P19838 | NFKB1 |
| T83145 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P19838 | NFKB1 |
| T60366 | DI0020 | African trypanosomiasis | [ICD-11: 1F51] | P11926 | ODC1 |
| T16347 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | P18031 | PTPN1 |
| T16347 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P18031 | PTPN1 |
| T16347 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | P18031 | PTPN1 |
| T16347 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P18031 | PTPN1 |
| T83145 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | P19838 | NFKB1 |
| T83145 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P19838 | NFKB1 |
| T61698 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | P60568 | IL2 |
| T61698 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P60568 | IL2 |
| T56556 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | Q9UNQ0 | ABCG2 |
| T56556 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | Q9UNQ0 | ABCG2 |
| T97035 | DI0007 | Acquired hypermelanosis | [ICD-11: ED60] | P14679 | TYR |
| T97035 | DI0008 | Acquired hypomelanotic disorder | [ICD-11: ED63] | P14679 | TYR |
| T93653 | DI0055 | Bone cancer | [ICD-11: 2B5Z] | O60911 | CTSV |
| T93653 | DI0087 | Chronic pain | [ICD-11: MG30] | O60911 | CTSV |
| T70518 | DI0037 | Asthma | [ICD-11: CA23] | P16152 | CBR1 |
| T85616 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P10599 | TXN |